Wednesday, 28 February 2018

Why Oppenheimer Global fund is focusing on biotech as rates rise

NEW YORK (Reuters) - The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks.


from Reuters: Business News http://ift.tt/2BU91oR

No comments:

Post a Comment

3 takeaways from our Davos panel on the future of robotics

5 AI and trade experts at Davos share their thoughts on the future of Robotics. INA FASSBENDER / AFP via Getty Images Digital twins are...